TNFA-863 polymorphism is associated with a reduced risk of Chronic Obstructive Pulmonary Disease: A replication study

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Córdoba Lanús, Elizabeth ^a   Baz Dávila, Rebeca ^a   de Torres, Juan P ^b   Rodríguez Pérez, María C ^a   Maca Meyer, Nicole ^a   Varo, Nerea ^b   Medina Coello, Chaxiraxi ^a   Aguirre Jaime, Armando ^a   Casanova, Ciro ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CAUCASIAN; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; RISK REDUCTION; SPAIN; TAIWAN; AGED; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053587422     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-132     Document Type: Article

References (41)

1. Wouters EF, Reynaert NL, Dentener MA, Vernooy JH. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection?. Proc Am Thorac Soc 2009, 6:638-647. 10.1513/pats.200907-073DP, 20008867.
2. Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNFα in pulmonary pathophysiology. Respir Res 2006, 7:125. 10.1186/1465-9921-7-125, 1613248, 17034639.
3. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001, (Suppl 34):50s-59s.
4. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax 2004, 59:574-580. 10.1136/thx.2003.019588, 1747070, 15223864.
5. de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-a production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996, 53:633-637.
6. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumour necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199. 10.1073/pnas.94.7.3195, 20345, 9096369.
7. Wu WS, McClain KL. DNA polymorphisms and mutations of the tumor necrosis factor-a (TNF-a) promoter in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res 1997, 17:631-635. 10.1089/jir.1997.17.631, 9355965.
8. Huang SL, Su CH, Chang SC. Tumour necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997, 156:436-1439.
9. Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:420-422.
10. Brøgger J, Steen VM, Eiken HG, Gulsvik A, Bakke P. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J 2006, 27:682-688. 10.1183/09031936.06.00057005, 16585076.
11. Seifart C, Dempfle A, Plagens A, Seifart U, Clostermann U, Müller B, Vogelmeier C, von Wichert P. TNF-a-, TNF-b-, IL- 6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 2005, 65:93-100. 10.1111/j.1399-0039.2005.00343.x, 15663746.
12. Tanaka G, Sandford AJ, Burkett K, Connett JE, Anthonisen NR, Paré PD, He JQ. Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J 2007, 29:34-41.
13. Chappell S, Daly L, Morgan K, Baranes TG, Roca J, Rabinovich R, Millar A, Donnelly SC, Keatings V, Macnee W, Stolk J, Hiemstra PS, Miniati M, Monti S, O'Connor CM, Kalsheker N. Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD. Eur Respir J 2007, 30:810-2. 10.1183/09031936.00057107, 17906092.
14. Gingo MR, Silveira LJ, Miller YE, Friedlander AL, Cosgrove GP, Chan ED, Maier LA, Bowler RP. Tumour necrosis factor gene polymorphisms are associated with COPD. Eur Respir J 2008, 31:1005-1012. 10.1183/09031936.00100307, 18256059.
15. Hersh CP, Demeo DL, Lange C, Litonjua AA, Reilly JJ, Kwiatkowski D, Laird N, Sylvia JS, Sparrow D, Speizer FE, Weiss ST, Silverman EK. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005, 33:71-78. 10.1165/rcmb.2005-0073OC, 2715305, 15817713.
16. Chen YC, Liu SF, Chin CH, Wu CC, Chen CJ, Chang HW, Wang YH, Chung YH, Chao TY, Lin MC. Association of Tumour Necrosis Factor-alpha-863C/A Gene Polymorphism with Chronic Obstructive Pulmonary Disease. Lung 2010, 188:339-47. 10.1007/s00408-010-9236-5, 20352242.
17. Messer G, Spengler U, Jung MC, Honold G, Blömer K, Pape GR, Riethmüller G, Weiss EH. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-b gene correlates with a variant amino acid in position 26 and a reduced level of TNF-b production. J Exp Med 1991, 173:209-219. 10.1084/jem.173.1.209, 2118757, 1670638.
18. Migita O, Noguchi E, Koga M, Jian Z, Shibasaki M, Migita T, Ito S, Ichikawa K, Matsui A, Arinami T. Haplotype analysis of a 100 kb region spanning TNF-LTA identifies a polymorphism in the LTA promoter region that is associated with atopic asthma susceptibility in Japan. Clin Exp Allergy 2005, 35:790-796. 10.1111/j.1365-2222.2005.02265.x, 15969671.
19. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. The nature of small airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653. 10.1056/NEJMoa032158, 15215480.
20. Tomasdottir H, Hjartarson H, Ricksten A, Wasslavik C, Bengtsson A, Ricksten SE. Tumour necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg 2003, 97:944-949.
21. Danilko KV, Korytina GF, Akhmidishina LZ, Ianbaeva DG, Zagidullin S, Victorova TV. Association of cytokines genes (ILL, IL1RN, TNF, LTA, IL6, IL8, IL0) polymorphic markers with chronic obstructive pulmonary disease. Mol Biol (Mosk) 2007, 41:26-36.
22. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555. 10.1164/rccm.200703-456SO, 17507545.
23. ATS Statement Guidelines for the Six-Minute Walk Test. Am J Resp Crit Care Med 2002, 166:111-117. ATS Statement.
24. Celli BR, Cote C, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The Body Mass Index, Airflow Obstruction, Dyspnea, Exercise Performance (BODE) Index in Chronic Obstructive Pulmonary Disease. N Engl J Med 2004, 350:1005-1012. 10.1056/NEJMoa021322, 14999112.
25. Cabrera de León A, González DA, Méndez LI, Aguirre-Jaime A, del Cristo Rodríguez Pérez M, Coello SD, Trujillo IC. Leptin and altitude in the cardiovascular diseases. Obes Res 2004, 12:1492-1498. 10.1038/oby.2004.186, 15483214.
26. Maca-Meyer N, Villar J, Pérez-Méndez L, Cabrera de León A, Flores C. A tale of aborigines, conquerors and slaves: Alu insertion polymorphism ante peopling of Canary Islands. Ann Hum Genet 2004, 68:600-605. 10.1046/j.1529-8817.2003.00125.x, 15598218.
27. Barret JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
28. Martínez A, Rubio A, Urcelay E, Fernández-Arquero M, De Las Heras V, Arroyo R, Villoslada P, Montalbán X, De La Concha EG. TNF-376A marks susceptibility to MS in the Spanish population: A replication study. Neurology 2004, 62:809-810.
29. Van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell DP, Kwiatkowski D. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kB transcription factors. Hum Mol Genet 2002, 11:1281-1289. 10.1093/hmg/11.11.1281, 12019209.
30. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, Breedveld FC, Verweij CL, van de Gaer L, Dams L, Crusius JB, García-Gonzalez A, van Oosten BW, Polman CH, Peña AS. THF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different group of patients. J Neuroimmunol 1997, 72:149-153. 10.1016/S0165-5728(96)00182-8, 9042107.
31. Raymond M, Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenecism. J Hered 1995, 86:248-249.
32. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction. Am J Hum Genet 2003, 73:1162-1169. 10.1086/379378, 1180495, 14574645.
33. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929. 10.1093/bioinformatics/btl268, 16720584.
34. Nyholt DR. A simple correction for multiple testing for SNPs in linkage disequilibrium with each other. Am J Hum Genet 2004, 74:765-769. 10.1086/383251, 1181954, 14997420.
35. Papatheodorou A, Latsi P, Vrettou C, Dimakou A, Chroneou A, Makrythanasis P, Kaliakatsos M, Orfanidou D, Roussos C, Kanavakis E, Tzetis M. Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-alpha gene: their association with obstructive pulmonary disease in Greek patients. Clin Biochem 2007, 40:843-850. 10.1016/j.clinbiochem.2007.03.024, 17509552.
36. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993, 16:180-186. 10.1006/geno.1993.1156, 8486354.
37. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003, 22:672-688. 10.1183/09031936.03.00040703, 14582923.
38. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K. Polymorphism of the 59-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998, 51:605-612. 10.1111/j.1399-0039.1998.tb03002.x, 9694352.
39. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A. A common functional polymorphism (C-A substitution at position -863) in the promoter region of the tumour necrosis factor-a (TNF-a) gene associated with reduced circulating levels of TNF-a. Hum Mol Genet 1999, 8:1443-1449. 10.1093/hmg/8.8.1443, 10400991.
40. Smolonska J, Wijmenga C, Postma DS, Boezen HM. Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Am J Respir Crit Care Med 2009, 180:618-631. 10.1164/rccm.200905-0722OC, 19608716.
41. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009, 360:2445-2454. 10.1056/NEJMra0804752, 19494220.